227 related articles for article (PubMed ID: 36490346)
41. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
Zhao R; Yang FT; Alexander DR
Cancer Cell; 2004 Jan; 5(1):37-49. PubMed ID: 14749125
[TBL] [Abstract][Full Text] [Related]
42. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
[TBL] [Abstract][Full Text] [Related]
43. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA
Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926
[TBL] [Abstract][Full Text] [Related]
44. Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Tan Y; Sementino E; Pei J; Kadariya Y; Ito TK; Testa JR
Cancer Biol Ther; 2015; 16(4):580-8. PubMed ID: 25793663
[TBL] [Abstract][Full Text] [Related]
45. USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha.
Sun W; Tan X; Shi Y; Xu G; Mao R; Gu X; Fan Y; Yu Y; Burlingame S; Zhang H; Rednam SP; Lu X; Zhang T; Fu S; Cao G; Qin J; Yang J
Cell Signal; 2010 Mar; 22(3):386-94. PubMed ID: 19874889
[TBL] [Abstract][Full Text] [Related]
46. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN.
Löwenberg M; Verhaar AP; Bilderbeek J; Marle Jv; Buttgereit F; Peppelenbosch MP; van Deventer SJ; Hommes DW
EMBO Rep; 2006 Oct; 7(10):1023-9. PubMed ID: 16888650
[TBL] [Abstract][Full Text] [Related]
47. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).
Yamaguchi T; Kimura J; Miki Y; Yoshida K
J Biol Chem; 2007 Nov; 282(47):33943-8. PubMed ID: 17897950
[TBL] [Abstract][Full Text] [Related]
48. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
49. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1.
Li L; Cui Y; Shen J; Dobson H; Sun G
Leuk Res; 2019 Mar; 78():12-20. PubMed ID: 30660961
[TBL] [Abstract][Full Text] [Related]
50. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
51. Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
Lambrou GI; Adamaki M; Hatziagapiou K; Vlahopoulos S
Curr Drug Res Rev; 2020; 12(2):131-149. PubMed ID: 32077838
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 4 inhibits IL-2-induced proliferation of a human T-leukemia cell line without interfering with p56-LCK kinase activation.
Torigoe T; O'Connor R; Fagard R; Fischer S; Santoli D; Reed JC
Cytokine; 1992 Sep; 4(5):369-76. PubMed ID: 1420998
[TBL] [Abstract][Full Text] [Related]
53. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
[TBL] [Abstract][Full Text] [Related]
54. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
[TBL] [Abstract][Full Text] [Related]
55. Dexamethasone induces rapid tyrosine-phosphorylation of ZAP-70 in Jurkat cells.
Bartis D; Boldizsár F; Szabó M; Pálinkás L; Németh P; Berki T
J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):147-54. PubMed ID: 16406604
[TBL] [Abstract][Full Text] [Related]
56. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
57. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
[TBL] [Abstract][Full Text] [Related]
58. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.
Bachmann PS; Gorman R; Papa RA; Bardell JE; Ford J; Kees UR; Marshall GM; Lock RB
Cancer Res; 2007 May; 67(9):4482-90. PubMed ID: 17483364
[TBL] [Abstract][Full Text] [Related]
59. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
[TBL] [Abstract][Full Text] [Related]
60. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]